Daphne Karydas

MLYS

Daphne Karydas serves as director at Mineralys Therapeutics, Inc. (MLYS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$764.8K

Net Position

Net Seller

$764.8K

Companies Traded

MLYS

Active Period

Nov 2025 – Apr 2026

2 total trades

Most Recent

Sell MLYS

Apr 2, 2026 · $75.0K

Daphne Karydas's Insider Trading at Mineralys Therapeutics, Inc. (MLYS)

Buys

0 · $0.00

Sells

2 · $764.8K

Total Shares Bought

Total Shares Sold

18,000

MLYS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 2, 2026	Sell	3,000	$25.00	$75.0K	6,200
Nov 13, 2025	Sell	15,000	$45.99	$689.8K	4,885

Related Insiders

David Malcom Rodman

officer: Chief Medical Officer

MLYSSell · Jun 12, 2026

Jon Congleton

director, officer: Chief Executive Officer

MLYSSell · Apr 15, 2026

RA CAPITAL MANAGEMENT, L.P.

director

MLYSBuy · Mar 31, 2026

Adam Scott Levy

officer: CFO and Secretary

MLYSSell · Jan 13, 2026

Brian Taylor Slingsby

Director

MLYSSell · Nov 21, 2025

Alexander M Gold

Director

MLYSSell · Nov 13, 2025

AKKARAJU SRINIVAS

MLYSBuy · Sep 8, 2025

Explore More Insider Trading Data

MLYS Insider Trading Activity

View all insider trades at Mineralys Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity